Medsea Estates Group PLC
04 July 2005
For immediate release 4 July 2005
MEDSEA ESTATES GROUP PLC ('MEDSEA' OR THE 'COMPANY')
MILLION POUNDS PROPERTY DEAL
Urbanilor S.l., a company in which Medsea Estates Group PLC holds a 5 per cent
interest, has bought development rights to a 693,159 sq m - approximately 7.5
million sq ft - plot of land in Aguilas, Murcia, Spain for €1,616,520
(approximately £1 million). Urbanilor intends to develop up to 578 residential
properties on the site, the first of which will be under construction by March
2006.
Medsea will supervise everything related to the sales and marketing of the
properties on behalf Urbanilor, and Medsea's subsidiary, Euromed, acting as
principle agent, is marketing the development in the UK and Ireland through its
links with some 150 independent property agents.
This is Euromed's second exclusive arrangement. Its first, earlier this year,
was with Promilorci SL for the 4.5 million sq ft Nuevo Torre Guil development
also in Murcia.
The project, known as the Torre del Obispo development, is within a large
forested area six miles from the city of Murcia, one of the most important
Spanish destinations for national and international tourism. The Murcia region
has experienced significant growth and ranks fifth for foreign investment in
Spain with Madrid and Barcelona taking the first two places.
The new homes will comprise of maisonettes, two bedroom two bathroom 970 sq ft
maisonettes; two-storey, two to three bedroom semi-detached houses; and
individual plots with prices starting at €135,000 for the maisonettes to
€240,000 for the semis.
- ends -
For further information contact:
Tony Gatehouse, Chairman
Medsea Estates Group PLC 0034 96 570 40 02
Juan Carlos Rodriguez Martinez, Chief Executive
Medsea Estates Group PLC 0034 96 570 40 02
Roland Cornish/
Noelle Greenaway
Beaumont Cornish Limited 0207 628 3396
Mark Sheppard 0161 228 1709
Midas
Terry Garrett/ Alex White
Weber Shandwick Square Mile 0207 067 0700
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.